INCYTE CORPORATION Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- INCYTE CORPORATION share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2011-12-31 was 74.02K shares.
- INCYTE CORPORATION share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2011-09-30 was 155.72K shares.
- INCYTE CORPORATION share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 2.59M shares, a 500.42% increase from fiscal 2024.
- INCYTE CORPORATION share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 430.56K shares, a 86.06% increase from fiscal 2023.
- INCYTE CORPORATION share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 231.42K shares, a 63.35% decline from fiscal 2022.
- INCYTE CORPORATION share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 631.35K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2025-12-31 | 2.59M shares 10-K · filed 2026-02-10 | |
| 2024-12-31 | 430.56K shares 10-K · filed 2025-02-10 | |
| 2023-12-31 | 231.42K shares 10-K · filed 2024-02-13 | |
| 2022-12-31 | 631.35K shares 10-K · filed 2023-02-07 | |
| 2011-12-31 | 74.02K shares derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | 2.29M shares 10-K · filed 2012-02-22 |
| 2011-09-30 | 155.72K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-27 | |
| 2010-12-31 | 1.70M shares 10-K · filed 2012-02-22 | |
| 2009-12-31 | 104.92K shares 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |